[Inhibition of angiogenesis in pancreatic carcinoma by cyclooxygenase-2 antisense oligodeoxynucleotides]
Related Experiment Video
Updated: Aug 30, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Xing-Peng Wang1, Chuan-Gao Xie, Yu-Wei Dong
1Department of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai 200080, China.
Objective:
To investigate the effect of cyclooxygenase-2 antisense oligodeoxynucleotides (COX-2 AS-ODNs) on the angiogenesis in pancreatic carcinoma and to evaluate the intermediary effect of prostaglandin 2 in this process.
Methods:
Specific targeting COX-2 AS-ODNs were designed and synthesized, and transfected into the PC3 human pancreatic carcinoma cells cultured in vitro. Fluorescence microscopy was used to observe the PC3 cells 0.12. 24, 40, and 72 hours after the transfection. the second cultured PC3 cells were divided into 5 groups: control group, Lipo group (transfected with Lipofectin only), C1 group (transfected with 1 micro g COX-2 AS-ODN + Lipo/well), C2 group (transfected with 2 micro g COX-2 AS-ODN + Lipo/well), and C3 group (transfected with 3 micro g COX-2 AS-ODN + Lipo/well). RT-PCR was used to observe the expression of COX-2 mRNA in the PC3 cells. The third batch of PC3 cells were transfected with 3 micro g COX-2 AS-ODN + Lipo/well, and the expression of COX-2 mRNA was observed 0, 12, 24, 48, and 72 hours later by RT-PCR. 3 micro g COX-2 AS-ODN + Lipo/bottle and 9 micro g COX-2 AS-ODN + Lipo/bottle were added into the cultured PC3 cells and Western blotting was used to observe the expression of COX-2 protein 24 hours later. 24 chicken eggs were inoculated with PC3 cells into the chorio-allantoic membrane and then divided equally into 5 groups; control group, Lipo group, COX-2 AS-ODN + Lipo group, and COX-2 AS-ODN + Lipo + PGE2 group. Leica microscopy was used to observe the angiogenesis in the transplanted carcinoma.
Results:
RT-PCR showed that the downregulation of expression of COX-2 mRNA in the PC3 cells with the increase of the COX-2 AS-ODN concentration, peaking at the concentration of 0.2 micro mol/L. The effect of COX-2 AS-ODN was strongest by the 12th hour after transfection and then began to decrease and basically disappeared 48 hours after. Western blotting showed that COX-2 AS-ODN, especially that of the concentration of the expression of 9 micro g/bottle, inhibited the expression of COX-2 AS-ODN. The angiogenesis of the transplanted carcinoma in the eggs was significantly inhibited in the Lipo + COX-2 AS-ODN group, the density of newly generated vessels in the Lipo + COX-2 AS-ODN + PGE2 group was between those of the other 2 groups.
Conclusion:
COX-2 AS-ODN significantly inhibits the angiogenesis in the pancreatic carcinoma. Endogenous COX-2 AS-ODN may play an important role in such a process and PGE2 may play an intermediate role therein.
Insights
Cyclooxygenase-2 antisense oligodeoxynucleotides (COX-2 AS-ODNs) effectively inhibit pancreatic cancer angiogenesis. Prostaglandin E2 (PGE2) appears to play an intermediate role in this process, highlighting a potential therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Context:
- Pancreatic carcinoma is a highly aggressive malignancy with limited treatment options.
- Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis.
- Cyclooxygenase-2 (COX-2) is implicated in promoting tumor angiogenesis.
Purpose:
- To investigate the anti-angiogenic effects of COX-2 antisense oligodeoxynucleotides (AS-ODNs) in pancreatic cancer.
- To elucidate the role of prostaglandin E2 (PGE2) as an intermediary in COX-2 AS-ODN-mediated angiogenesis inhibition.
Summary:
- Specific COX-2 AS-ODNs were synthesized and transfected into PC3 human pancreatic carcinoma cells.
- RT-PCR and Western blotting confirmed dose- and time-dependent downregulation of COX-2 mRNA and protein expression.
- In vivo studies on chicken chorioallantoic membranes demonstrated significant inhibition of tumor angiogenesis by COX-2 AS-ODNs.
Impact:
- COX-2 AS-ODNs demonstrate significant potential as a therapeutic strategy to inhibit pancreatic cancer angiogenesis.
- The findings suggest that targeting COX-2 signaling, potentially involving PGE2, could be a viable approach for pancreatic cancer treatment.
- This research provides a foundation for further investigation into the clinical application of AS-ODN therapy for pancreatic cancer.
More Related Videos
10:01Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Regulation of Angiogenesis and Blood Supply
Experimental RNAi
Mechanism of Angiogenesis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...